Stay updated on Pembrolizumab in Lymphoma Subtypes Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphoma Subtypes Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added to the page, replacing the previous Revision: v3.5.3. This reflects a new version of the page content without altering the study details.
    Difference
    0.0%
    Check dated 2026-05-15T14:28:06.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page’s footer “Revision” value was updated from v3.5.2 to v3.5.3, indicating a minor platform/version change without altering study details.
    Difference
    0.0%
    Check dated 2026-04-24T05:52:48.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Version bump from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:25:51.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    - Added inclusion criterion: B-cell lymphoma unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma.
    Difference
    0.0%
    Check dated 2026-04-02T14:59:47.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    A new revision, v3.5.0, has been added; the previous revision, v3.4.3, has been removed.
    Difference
    0.0%
    Check dated 2026-03-19T00:01:38.000Z thumbnail image
  9. Check
    79 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3 and no longer shows Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T20:08:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphoma Subtypes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.